We are live on ! Find out more
SLG

Stanley-Laman Group Portfolio holdings

AUM $814M
1-Year Est. Return 40.24%
This Fund
S&P 500
This Quarter Est. Return
-1.83%
1 Year Est. Return
+40.24%
3 Year Est. Return
+82.87%
5 Year Est. Return
+77.64%
10 Year Est. Return
+275.61%
AUM
$696M
AUM Growth
-$17.3M
Cap. Flow
-$537K
Cap. Flow %
-0.08%
Top 10 Hldgs %
15.81%
Holding
288
New
40
Increased
95
Reduced
57
Closed
17

Top Buys

Rank Stock Value
1
FRSH icon
Freshworks
FRSH
+$10.8M
2
JBL icon
Jabil
JBL
+$4.39M
3
GSK icon
GSK
GSK
+$4.1M
4
NOV icon
NOV
NOV
+$3.97M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$3.76M

Top Sells

Rank Stock Value
1
HCP
HashiCorp, Inc. Class A Common Stock
HCP
+$11.3M
2
VNM icon
VanEck Vietnam ETF
VNM
+$7M
3
CHX
ChampionX
CHX
+$4.45M
4
GPN icon
Global Payments
GPN
+$4.34M
5
UNH icon
UnitedHealth
UNH
+$4.03M

Sector Composition

Rank Sector Weight
1 Technology 31.67%
2 Industrials 12.69%
3 Healthcare 11.3%
4 Energy 7.93%
5 Financials 4.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VNM icon
201
VanEck Vietnam ETF
VNM
$491M
– –
-503,817
Closed -$7M
HCP
202
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
– –
-418,613
Closed -$11.3M
5 6 7 8
9

Similar funds

VFG
Victory Financial Group Austin, Texas $814M AUM 18.17% 1-Year Est. Return
KCP
Kera Capital Partners San Jose, California $815M AUM 46.39% 1-Year Est. Return
AR
Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return
CICI
Capital Investment Counsel Inc Raleigh, North Carolina $816M AUM 34.73% 1-Year Est. Return
UAG
United Advisor Group Cincinnati, Ohio $811M AUM 18.32% 1-Year Est. Return
PS
Portfolio Strategies Monsey, New York $811M AUM 28.91% 1-Year Est. Return
BC
Brio Consultants San Francisco, California $818M AUM 13.48% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return

Stanley-Laman Group's Q2 2024 Portfolio in Review

As of Q2 2024, Stanley-Laman Group held 288 positions worth $696M, down 2.4% from $713M the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Stanley-Laman Group's Q2 2024 filing shows 40 new, 95 increased, 57 reduced and 17 closed positions. Its largest new stake was Freshworks: 719,687 shares worth $9.13M. The largest sale was HashiCorp, Inc. Class A Common Stock, an estimated $11.3M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 33% a quarter earlier, followed by Industrials and Healthcare.

  • Stanley-Laman Group's largest Q2 2024 buy was Freshworks: 719,687 shares worth $9.13M.
  • Stanley-Laman Group added most to GSK in Q2 2024, an estimated $4.1M increase.
  • Stanley-Laman Group's biggest Q2 2024 reduction was Eli Lilly, cutting an estimated $3.55M.
  • Stanley-Laman Group fully exited HashiCorp, Inc. Class A Common Stock in Q2 2024, selling an estimated $11.3M.
  • Stanley-Laman Group's ten largest holdings make up 16% of its $696M portfolio in Q2 2024.
  • Stanley-Laman Group opened 40 new positions and closed 17 in Q2 2024.
  • Stanley-Laman Group's portfolio value fell 2.4% quarter-over-quarter to $696M.

Based on Stanley-Laman Group's 13F filing for Q2 2024, filed 18 Jul 2024.